Weight loss medications like Zepbound are not recommended during pregnancy and should be discontinued when pregnancy is recognized
During the weight loss phase changes in food selection, reduction in appetite, and changes in gastrointestinal hormone levels are known to play a significant role [3]
Private insurers have restricted coverage, or added new approval requirements, and now the state government is doing the same
However, hormonal changes may influence appetite and body composition, making a holistic approach including nutrition, exercise and sleep even more important
GLP-1 agonists have demonstrated anti-inflammatory effects in the central nervous system, potentially breaking this feedback loop
Reaching your target weight naturally raises questions about continued use